AGA guidelines on anti-obesity meds
The substantial increase in obesity prevalence in the United States – from 30.5% to 41.9% in just the 2 decades from 2000 to 2020 –
The substantial increase in obesity prevalence in the United States – from 30.5% to 41.9% in just the 2 decades from 2000 to 2020 –
This is our last issue of this year, and what a year it has been in the diabetes world in general and in the UK
Compared with BMI’s relatively quick acceptance into clinical practice, obesity has only recently been recognised as a disease. Historically, obesity has been viewed negatively as
A recent study has found that patients with Type 1 diabetes had an increased risk of obstructive sleep apnoea. The study found that the risk
Phil Aird-Mash, CEO of the ITC Travel Group, Chair of ACC Aviation and Traveltek Ltd, has been appointed JDRF’s Chair of the Board of Directors.
BHR markets and supports the use of their point of care diagnostic products for use in GP surgeries, hospitals and other locations, and is now
Adocia has announced the establishment of a first proof of concept for its’ AdoShell Islets implant by achieving glycaemic control without insulin injections or immunosuppression
The charity Diabetes Research and Wellness Foundation (DRWF) will be back in Hartlepool for our first Diabetes Wellness Day North since 2019 when it will
Medtronic has announced positive results from a study of its next-generation MiniMed 780G automated insulin delivery system. Its ADAPT study enlisted 82 individuals with Type
Study may explain why people with diabetes may develop tooth decay. People with both Type 1 and Type 2 diabetes are prone to tooth decay,